A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia (COVACTA)
Projektbeschreibung
This study will evaluate the efficacy, safety, pharmacodynamics, and pharmacokinetics of tocilizumab (TCZ) compared with a matching placebo in combination with standard of care (SOC) in hospitalized patients with severe COVID-19 pneumonia.
Projektziele
Ziel dieses Projekts ist es, Kenntnisse zur Wirksamkeit, Sicherheit, Pharmakokinetik und Pharmakodynamik von Tocilizumab bei Patienten mit schwerem Covid-19 Krankheitsverlauf zu gewinnen.
